The field of gynecological oncology has witnessed significant advancements in recent years, particularly in the diagnosis and surgical treatment of gynecological tumors. Despite these advancements, there are ongoing debates and unresolved questions. For instance, the role of minimally invasive surgery for microscopic tumors or in FIGO stage IB1 after conization in cervical cancer remains contentious. Similarly, the introduction of molecular characterization in the new FIGO classification for endometrial cancer patients has raised concerns about its feasibility and availability across all gynecological cancer centers globally. Furthermore, the adjuvant treatment for endometrial cancer based on molecular classification is a recent development, and consistent prospective data are still lacking.
This Research Topic aims to address these gaps and uncertainties by focusing on new indications in the diagnosis and treatment of gynecological tumors. The goal is to provide a comprehensive update on the latest evidence, significant studies, and dominant theories in this field. The research will test the hypotheses related to the effectiveness and applicability of recent innovations, such as the use of molecular classification in endometrial cancer treatment and the role of minimally invasive surgery in cervical cancer.
To achieve this, the research will be limited to the diagnosis and surgical treatment of gynecological tumors. We welcome articles addressing, but not limited to, the following themes:
• The role and effectiveness of minimally invasive surgery in cervical cancer;
• The feasibility and impact of molecular characterization in the new FIGO classification for endometrial cancer;
• The use of adjuvant treatment based on molecular classification in endometrial cancer;
• The selection of patients for interval debulking surgery versus primary debulking surgery in ovarian cancer;
• The potential role of hormone therapy in ovarian cancer, cervical cancer, relapse, and advanced endometrial cancer.
The field of gynecological oncology has witnessed significant advancements in recent years, particularly in the diagnosis and surgical treatment of gynecological tumors. Despite these advancements, there are ongoing debates and unresolved questions. For instance, the role of minimally invasive surgery for microscopic tumors or in FIGO stage IB1 after conization in cervical cancer remains contentious. Similarly, the introduction of molecular characterization in the new FIGO classification for endometrial cancer patients has raised concerns about its feasibility and availability across all gynecological cancer centers globally. Furthermore, the adjuvant treatment for endometrial cancer based on molecular classification is a recent development, and consistent prospective data are still lacking.
This Research Topic aims to address these gaps and uncertainties by focusing on new indications in the diagnosis and treatment of gynecological tumors. The goal is to provide a comprehensive update on the latest evidence, significant studies, and dominant theories in this field. The research will test the hypotheses related to the effectiveness and applicability of recent innovations, such as the use of molecular classification in endometrial cancer treatment and the role of minimally invasive surgery in cervical cancer.
To achieve this, the research will be limited to the diagnosis and surgical treatment of gynecological tumors. We welcome articles addressing, but not limited to, the following themes:
• The role and effectiveness of minimally invasive surgery in cervical cancer;
• The feasibility and impact of molecular characterization in the new FIGO classification for endometrial cancer;
• The use of adjuvant treatment based on molecular classification in endometrial cancer;
• The selection of patients for interval debulking surgery versus primary debulking surgery in ovarian cancer;
• The potential role of hormone therapy in ovarian cancer, cervical cancer, relapse, and advanced endometrial cancer.